Conflict of Interest in the Debate over Calcium-Channel Antagonists
- 4 June 1998
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 338 (23) , 1696-1698
- https://doi.org/10.1056/nejm199806043382313
Abstract
The article by Stelfox et al. (Jan. 8 issue)1 is ambiguous and undermined by a self-fulfilling prophecy. The authors concluded that there is no evidence of conflict of interest but not before compiling confusing information to the contrary.Keywords
This publication has 7 references indexed in Scilit:
- Conflict of Interest in the Debate over Calcium-Channel AntagonistsNew England Journal of Medicine, 1998
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of internal medicine (1960), 1997
- JNC VI: timing is everythingThe Lancet, 1997
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997
- Long‐Term Survival and Use of Antihypertensive Medications in Older PersonsJournal of the American Geriatrics Society, 1995
- Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formularyPublished by American Medical Association (AMA) ,1994
- Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)The American Journal of Cardiology, 1990